Harder, better, faster, stronger: biochemistry and biophysics in the immunosurveillance concert
- PMID: 34973924
- PMCID: PMC8810625
- DOI: 10.1016/j.it.2021.12.003
Harder, better, faster, stronger: biochemistry and biophysics in the immunosurveillance concert
Abstract
Antitumor immunosurveillance is triggered by immune cell recognition of characteristic biochemical signals on the surfaces of cancer cells. Recent data suggest that the mechanical properties of cancer cells influence the strength of these signals, with physically harder target cells (more rigid) eliciting better, faster, and stronger cytotoxic responses against metastasis. Using analogies to a certain electronic music duo, we argue that the biophysical properties of cancer cells and their environment can adjust the volume and tone of the antitumor immune response. We also consider the potential influence of biomechanics-based immunosurveillance in disease progression and posit that targeting the biophysical properties of cancer cells in concert with their biochemical features could increase the efficacy of immunotherapy.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests No interests are declared.
Figures


Similar articles
-
Evidence and therapeutic implications of biomechanically regulated immunosurveillance in cancer and other diseases.Nat Nanotechnol. 2024 Mar;19(3):281-297. doi: 10.1038/s41565-023-01535-8. Epub 2024 Jan 29. Nat Nanotechnol. 2024. PMID: 38286876 Review.
-
Long Non-Coding RNAs (lncRNAs) in Response and Resistance to Cancer Immunosurveillance and Immunotherapy.Cells. 2021 Nov 26;10(12):3313. doi: 10.3390/cells10123313. Cells. 2021. PMID: 34943820 Free PMC article. Review.
-
Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance.Immunity. 2013 Jul 25;39(1):74-88. doi: 10.1016/j.immuni.2013.06.014. Immunity. 2013. PMID: 23890065 Review.
-
NKG2D signaling in cancer immunosurveillance.Int J Cancer. 2015 Apr 15;136(8):1741-50. doi: 10.1002/ijc.28775. Epub 2014 Mar 3. Int J Cancer. 2015. PMID: 24615398 Review.
-
Immunosurveillance in clinical cancer management.CA Cancer J Clin. 2024 Mar-Apr;74(2):187-202. doi: 10.3322/caac.21818. Epub 2023 Oct 25. CA Cancer J Clin. 2024. PMID: 37880100 Free PMC article. Review.
Cited by
-
Cancer cells suppress NK cell activity by actin-driven polarization of inhibitory ligands to the immunological synapse.Proc Natl Acad Sci U S A. 2025 Aug 12;122(32):e2503259122. doi: 10.1073/pnas.2503259122. Epub 2025 Aug 5. Proc Natl Acad Sci U S A. 2025. PMID: 40763024 Free PMC article.
-
Mechanical forces amplify TCR mechanotransduction in T cell activation and function.Appl Phys Rev. 2024 Mar;11(1):011304. doi: 10.1063/5.0166848. Appl Phys Rev. 2024. PMID: 38434676 Free PMC article. Review.
-
Insights into intercellular receptor-ligand binding kinetics in cell communication.Front Bioeng Biotechnol. 2022 Jun 28;10:953353. doi: 10.3389/fbioe.2022.953353. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35837553 Free PMC article. Review.
-
Macrophage metabolism in nonalcoholic fatty liver disease.Front Immunol. 2023 Oct 4;14:1257596. doi: 10.3389/fimmu.2023.1257596. eCollection 2023. Front Immunol. 2023. PMID: 37868954 Free PMC article. Review.
-
Actin cytoskeleton remodeling at the cancer cell side of the immunological synapse: good, bad, or both?Front Immunol. 2023 Oct 5;14:1276602. doi: 10.3389/fimmu.2023.1276602. eCollection 2023. Front Immunol. 2023. PMID: 37869010 Free PMC article. Review.
References
-
- Freeman SA and Grinstein S (2014) Phagocytosis: receptors, signal integration, and the cytoskeleton. Immunol Rev 262 (1), 193–215. - PubMed
-
- Harwood NE and Batista FD (2010) Early events in B cell activation. Annu Rev Immunol 28, 185–210. - PubMed
-
- Wei SC et al. (2018) Fundamental Mechanisms of Immune Checkpoint Blockade Therapy. Cancer Discov 8 (9), 1069–1086. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical